Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.94
-0.17 (-2.78%)
At close: Apr 2, 2026, 4:00 PM EDT
6.01
+0.07 (1.18%)
After-hours: Apr 2, 2026, 5:59 PM EDT
Ardelyx Employees
Ardelyx had 489 employees as of December 31, 2025. The number of employees increased by 94 or 23.80% compared to the previous year.
Employees
489
Change (1Y)
94
Growth (1Y)
23.80%
Revenue / Employee
$832,965
Profits / Employee
-$125,969
Market Cap
1.46B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 489 | 94 | 23.80% |
| Dec 31, 2024 | 395 | 128 | 47.94% |
| Dec 31, 2023 | 267 | 134 | 100.75% |
| Dec 31, 2022 | 133 | 47 | 54.65% |
| Dec 31, 2021 | 86 | -43 | -33.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nuvation Bio | 298 |
| Maze Therapeutics | 141 |
| Nanobiotix | 103 |
| Rapport Therapeutics | 84 |
ARDX News
- 1 day ago - Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - GlobeNewsWire
- 21 days ago - Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award - GlobeNewsWire
- 24 days ago - Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C - GlobeNewsWire
- 4 weeks ago - Ardelyx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions - GlobeNewsWire
- 5 weeks ago - Why Ardelyx's Offensive Strategy Doesn't Move The Needle - Seeking Alpha
- 5 weeks ago - Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability - Seeking Alpha
- 5 weeks ago - Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops - Benzinga